Summary:
- Phil Low, a renowned Purdue University drug discovery scholar, passed away at the age of 78. He was known for his groundbreaking work in developing targeted cancer therapies.
- Low's discoveries led to the creation of several life-saving drugs, including Farletuzumab, which has been used to treat ovarian cancer. His research focused on finding ways to selectively target and deliver drugs to cancer cells while minimizing harm to healthy cells.
- Throughout his career, Low received numerous awards and honors for his contributions to the field of drug discovery. He was recognized for his innovative approach and his dedication to improving the lives of patients with cancer and other diseases.